In the world there are a huge number of countries. All states are unevenly developed. There are highly developed rich countries with a high level of health, expensive and high-quality medicine and a state with a low level of economic development, in which medical services are not developed and are inaccessible to the majority of the population. The level of health in these countries is very low, there is no diagnosis of diseases at an early stage, and often there is none at all. Because of untimely diagnosis, underdeveloped economic states are often the source of the spread of pandemics and epidemics, and their life expectancy is very low.
Aimedis is a healthcare platform whose goal is to make health services accessible not only to people from rich countries with highly developed medicine, but also to people from developing countries from around the world.
The platform will use the technology of blockchain and artificial intelligence. It is designed to store medical information, maps, analyzes, snapshots and other data. The goal of the platform is to unite patients, clinics, doctors, pharmaceutical companies in one place. The user can upload to the platform any confidential medical information about his health. In this case, this information will be in private. Only those people to whom the user can provide personal access can see it. For example, the patient will provide documents to consult a doctor.
The Aimedis platform was launched in the third quarter of 2017 and currently operates in collaboration with more than 20 hospitals in three countries. Since its launch, Aimedis has already served more than 10,000 patients. This shows how much medical services in the world are in demand and how quickly the platform.
The work of the Aimedis platform is provided by two blockchains, private and public, thus allowing the storage of both private personal information of the user and information that is publicly available. Both chains are interconnected.
The Aimedis platform provides not only a network from the patient to the doctor, but also a special network for communicating to the patients among themselves, developing a community of patients. This network also stimulates contributions in the form of AIM tokens and contributes to the growth in the demand for AIM tokens, as all calculations in the network occur in AIM tokens. On the platform, patients can control their data and even sell them, while earning AIM tokens.
Aimedis is headed by a team of world-class doctors and medical industry professionals.
In addition to storage and information management, the platform provides video chats for physicians' consultations with patients, chat rooms for communication between patients, various patient groups are created, so that sick people can communicate with each other and support each other. In the open version of the platform, online recipes will be available, online receptions, training sessions for patients, as well as special classes for people who care for patients.
Also, for more accurate online diagnosis and correct and timely diagnosis, fitness trackers and various monitoring tools such as ECG or blood pressure monitors.
Aimedis works with clinics in Europe and Asia and participates in scientific research to save human lives.
AIM tokens are used to pay for platform services on online advice and other services.
AIM tokens will be paid to volunteers who take part in projects of pharmaceutical companies and in scientific researches.
The Aimedis platform was launched in closed mode in the 3rd quarter of 2017. At the moment, the platform has received the ISO 21007 safety certificate and has been tested by doctors and medical institutions. In the 4th quarter of 2017, German medical institutions joined the platform.
The platform has an easy and intuitive interface that allows even inexperienced users to work with it without special knowledge.
Presale has already begun. The price of AIM tokens is 0.12 $.
In the third quarter of 2018, the Asian cooperation program will start, and in the 4th quarter of 2018, the full launch of the open platform is planned.